[HTML][HTML] Useful in vitro techniques to evaluate the mucoadhesive properties of hyaluronic acid-based ocular delivery systems

A Graça, LM Gonçalves, S Raposo, HM Ribeiro… - Pharmaceutics, 2018 - mdpi.com
Polymer-based eye drops are the most used drug delivery system to treat dry eye disease
(DED). Therefore, the mucoadhesion between the polymer and the ocular mucin is crucial to …

[HTML][HTML] Chitosan-based in situ gels for ocular delivery of therapeutics: a state-of-the-art review

T Irimia, CE Dinu-Pîrvu, MV Ghica, D Lupuleasa… - Marine drugs, 2018 - mdpi.com
Ocular in situ gels are a promising alternative to overcome drawbacks of conventional eye
drops because they associate the advantages of solutions such as accuracy and …

Chitosan and its role in ocular therapeutics

S Wadhwa, R Paliwal, S Rai Paliwal… - Mini reviews in …, 2009 - ingentaconnect.com
From the past few decades, tremendous awareness has been laid on the use of natural
polymers in ocular drug delivery. Chitosan, a modified natural carbohydrate polymer, has …

Nanogel loaded with surfactant based nanovesicles for enhanced ocular delivery of acetazolamide

RS Abdel-Rashid, DA Helal, MM Omar… - International Journal of …, 2019 - Taylor & Francis
Objective: Intraocular pressure has always been a great challenge for topical ophthalmic
drugs. The study aimed to develop ocular surfactant based nanovesicles (NVs) carried in …

The use of mucoadhesive polymers in ocular drug delivery

A Ludwig - Advanced drug delivery reviews, 2005 - Elsevier
In the present update on mucoadhesive ocular dosage forms, the tremendous advances in
the biochemistry of mucins, the development of new polymers, the use of drug complexes …

Chitosan nanoparticles of 5-fluorouracil for ophthalmic delivery: characterization, in-vitro and in-vivo study

RC Nagarwal, PN Singh, S Kant, P Maiti… - Chemical and …, 2011 - jstage.jst.go.jp
The aim of this investigation was to develop 5-fluorouracil (5-FU) loaded chitosan
nanoparticles (CH-DNPs) for ophthalmic delivery. CH-DNPs were fabricated by ionotropic …

Ocular drug delivery–a look towards nanobioadhesives

LC du Toit, V Pillay, YE Choonara… - Expert opinion on …, 2011 - Taylor & Francis
Importance of the field: A major challenge emanating in the design of topical ophthalmic
preparations is their short precorneal residence time. Retention of a drug delivery system in …

Improving the topical ocular pharmacokinetics of an immunosuppressant agent with mucoadhesive nanoemulsions: Formulation development, in-vitro and in-vivo …

S Akhter, M Anwar, MA Siddiqui, I Ahmad… - Colloids and Surfaces B …, 2016 - Elsevier
Topical ocular conditions such as cornea transplant rejection and keratoconjunctivitis sicca
(so called dry eye disease) require therapeutic concentration of immunosuppressant onto …

Mucoadhesive effect of thiolated PEG stearate and its modified NLC for ocular drug delivery

J Shen, Y Wang, Q Ping, Y Xiao, X Huang - Journal of controlled release, 2009 - Elsevier
This study was to develop a thiolated non-ionic surfactant, cysteine-polyethylene glycol
stearate (Cys-PEG-SA), for the assembling of nanoparticulate ocular drug delivery system …

Preparation of cholesterol-modified chitosan self-aggregated nanoparticles for delivery of drugs to ocular surface

X Yuan, H Li, Y Yuan - Carbohydrate Polymers, 2006 - Elsevier
Cholesterol hydrophobically modified chitosan (CS-CH) containing 1.7–4.7 cholesterol
groups per 100 anhydroglucosamine units of chitosan were synthesized by an EDC …